CN Patent

CN102203253B — 用于dmd的多外显子跳跃组合物

Assigned to Sarepta Therapeutics Inc · Expires 2016-04-06 · 10y expired

What this patent protects

提供了能够结合人肌营养不良蛋白基因中选定的靶位点以便诱导外显子跳跃的反义分子，和使用其治疗肌营养不良的方法。

USPTO Abstract

提供了能够结合人肌营养不良蛋白基因中选定的靶位点以便诱导外显子跳跃的反义分子，和使用其治疗肌营养不良的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102203253B
Jurisdiction
CN
Classification
—
Expires
2016-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Sarepta Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.